March 1st, 2023 | Webinar | Join our webinar for an insightful discussion with LSK to learn how leading South Korean biopharma firms are navigating evolving regulatory requirements and seizing the opportunity provided by advancements in end-to-end safety automation.
Key topics will include:
- The impact of new regulatory requirements, including MFDS E2B(R3)
- How firms are navigating this changing regulatory landscape
- Recent trends that are driving industry need for safety automation
- How firms are achieving their automation goals
- CRO-specific challenges and opportunities